Viewing nowYoungjin Glitazone Tablet (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 200706386 · Notified 2007.06.04 · Insurance code 642401020
Effectiveness in improving type 2 diabetes (blood sugar control)
This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with diet and exercise and may be used in combination with sulfonylureas, metformin or insulin when there is no improvement in blood sugar with other oral hypoglycemics. For patients with type 2 diabetes, nutrition counseling, weight loss, and regular exercise are very important, and these efforts are necessary not only for initial treatment but also for maintaining the effectiveness of drug therapy. This medication effectively improves blood sugar control in patients.
This medication is taken orally once a day, regardless of meals. As monotherapy, it can be started at 15 mg once a day, and if necessary may be increased to 30 mg once a day. For combination therapy, the initial dose is 15 mg once a day. The maximum recommended dose should not exceed 30 mg once a day.
There is no experience with pediatric use for children under 18 years, and thus its administration is not recommended.
This medication is used to treat type 2 diabetes and is effective in lowering blood sugar only when insulin is present. This medication can put a strain on the heart, so it should not be used in patients with heart failure or a history of heart failure. If symptoms of heart failure such as sudden weight gain, shortness of breath, or swelling occur during treatment with this medication, immediate medical attention should be sought. Additionally, this medication can cause fluid retention, which may worsen heart failure, so patients with cardiovascular disease should use it with caution. This medication should not be administered to patients with bladder cancer or a history of bladder cancer, and any occurrence of urinary problems or hematuria should be reported to a physician immediately. Patients with impaired liver function or severe renal disease should not take this medication. Women who are pregnant or may become pregnant should not use this medication, and premenopausal women should use appropriate contraception as this medication may promote ovulation, increasing the likelihood of pregnancy. Regular blood sugar and liver function tests are necessary during treatment with this medication, and there is a risk of weight gain or swelling, as well as hypoglycemic symptoms, so caution is required. As there is a risk of hypoglycemia, dose adjustments may be necessary when used in combination with insulin or other hypoglycemic agents. Elderly patients or those with diminished kidney function should also use this medication cautiously, and side effects such as headache, upper respiratory infection, muscle pain, and edema may occur. In case of overdose, there may not be any specific symptoms, but appropriate treatment is necessary depending on the symptoms. This medication has not been shown to be safe and effective in children, so it is not used in this population. Finally, this medication should be kept out of reach of children and stored in its original container.
Edema, congestive heart failure, heart failure, severe swelling, difficulty breathing, shortness of breath, liver abnormalities (jaundice), myocardial infarction, stroke, elevated blood pressure, cardiac failure, hives, severe allergic reactions, severe skin adverse reactions, bladder cancer, significant neurological symptoms, seizures, altered consciousness, visual disturbances, paralysis, high fevers, severe rashes, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, pallor, cold sweat, serious neurological symptoms
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is not exposed to light and air, and moisture should be avoided. The recommended storage temperature is between 15 degrees Celsius to 30 degrees Celsius, with a preference for a cool place near 25 degrees Celsius.
White to grayish round and convex tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.